메뉴 건너뛰기




Volumn 23, Issue 3, 2011, Pages 331-341

Regression models for analyzing costs and their determinants in health care: An introductory review

Author keywords

Censoring; Cost analysis; Skewness; Zero cost

Indexed keywords

ARTICLE; COMORBIDITY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 79956038904     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzr010     Document Type: Article
Times cited : (136)

References (86)
  • 1
    • 0026884262 scopus 로고
    • Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?
    • Drummond M. Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status? Health Econ 1992;1:85-92.
    • (1992) Health Econ , vol.1 , pp. 85-92
    • Drummond, M.1
  • 2
    • 78049346289 scopus 로고    scopus 로고
    • Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods
    • Roberts RR, Scott RD, 2nd, Hota B et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010;48:1026-35.
    • (2010) Med Care , vol.48 , pp. 1026-1035
    • Roberts, R.R.1    Scott 2nd, R.D.2    Hota, B.3
  • 3
    • 77954102849 scopus 로고    scopus 로고
    • Is there a relationship between early statin compliance and a reduction in healthcare utilization?
    • Aubert RE, Yao J, Xia F et al. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care 2010;16:459-66.
    • (2010) Am J Manag Care , vol.16 , pp. 459-466
    • Aubert, R.E.1    Yao, J.2    Xia, F.3
  • 4
    • 0034939933 scopus 로고    scopus 로고
    • Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
    • Gabriel SE, Wagner JL, Zinsmeister AR et al. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum 2001;44:1504-14.
    • (2001) Arthritis Rheum , vol.44 , pp. 1504-1514
    • Gabriel, S.E.1    Wagner, J.L.2    Zinsmeister, A.R.3
  • 5
    • 0033203745 scopus 로고    scopus 로고
    • Does the severity of mood and anxiety symptoms predict health care utilization?
    • Nease DE, Jr, Volk RJ, Cass AR. Does the severity of mood and anxiety symptoms predict health care utilization? J Fam Pract 1999;48:769-77.
    • (1999) J Fam Pract , vol.48 , pp. 769-777
    • Nease Jr, D.E.1    Volk, R.J.2    Cass, A.R.3
  • 6
    • 22244435962 scopus 로고    scopus 로고
    • Incorporation of uncertainty in health economic modelling studies
    • O'Hagan A, McCabe C, Akehurst R et al. Incorporation of uncertainty in health economic modelling studies. Pharmacoeconomics 2005;23:529-36.
    • (2005) Pharmacoeconomics , vol.23 , pp. 529-536
    • O'Hagan, A.1    McCabe, C.2    Akehurst, R.3
  • 7
    • 0030011253 scopus 로고    scopus 로고
    • Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial
    • Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996;15:1447-58.
    • (1996) Stat Med , vol.15 , pp. 1447-1458
    • Chaudhary, M.A.1    Stearns, S.C.2
  • 8
    • 0024989695 scopus 로고
    • The CE plane: a graphic representation of costeffectiveness
    • Black WC. The CE plane: a graphic representation of costeffectiveness. Med Decis Making 1990;10:212-4.
    • (1990) Med Decis Making , vol.10 , pp. 212-214
    • Black, W.C.1
  • 9
    • 0037232949 scopus 로고    scopus 로고
    • Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies
    • Zethraeus N, Johannesson M, Jonsson B et al. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003;21:39-48.
    • (2003) Pharmacoeconomics , vol.21 , pp. 39-48
    • Zethraeus, N.1    Johannesson, M.2    Jonsson, B.3
  • 11
    • 0030179629 scopus 로고    scopus 로고
    • Confidence intervals for costeffectiveness ratios: an application of Fieller's theorem
    • Willan AR, O'Brien BJ. Confidence intervals for costeffectiveness ratios: an application of Fieller's theorem. Health Econ 1996;5:297-305.
    • (1996) Health Econ , vol.5 , pp. 297-305
    • Willan, A.R.1    O'Brien, B.J.2
  • 12
    • 0035875885 scopus 로고    scopus 로고
    • Incremental net benefit in randomized clinical trials
    • Willan AR, Lin DY. Incremental net benefit in randomized clinical trials. Stat Med 2001;20:1563-74.
    • (2001) Stat Med , vol.20 , pp. 1563-1574
    • Willan, A.R.1    Lin, D.Y.2
  • 13
    • 0031967923 scopus 로고    scopus 로고
    • Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results
    • Tambour M, Zethraeus N. Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results. Health Econ 1998;7:143-7.
    • (1998) Health Econ , vol.7 , pp. 143-147
    • Tambour, M.1    Zethraeus, N.2
  • 15
    • 0030916397 scopus 로고    scopus 로고
    • The negative side of cost-effectiveness analysis
    • author reply 1932-3
    • Stinnett AA, Mullahy J. The negative side of cost-effectiveness analysis. J Am Med Assoc 1997;277:1931-2; author reply 1932-3.
    • (1997) J Am Med Assoc , vol.277 , pp. 1931-1932
    • Stinnett, A.A.1    Mullahy, J.2
  • 16
    • 0031900689 scopus 로고    scopus 로고
    • Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
    • Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18(2 Suppl):S68-80.
    • (1998) Med Decis Making , vol.18 , Issue.2 SUPPL.
    • Stinnett, A.A.1    Mullahy, J.2
  • 17
    • 0036767312 scopus 로고    scopus 로고
    • Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data
    • Stevens JW, O'Hagan A. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data. Int J Technol Assess Health Care 2002;18:782-90.
    • (2002) Int J Technol Assess Health Care , vol.18 , pp. 782-790
    • Stevens, J.W.1    O'Hagan, A.2
  • 18
    • 0032879736 scopus 로고    scopus 로고
    • Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals
    • Severens JL, De Boo TM, Konst EM. Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals. Int J Technol Assess Health Care 1999;15:608-14.
    • (1999) Int J Technol Assess Health Care , vol.15 , pp. 608-614
    • Severens, J.L.1    De Boo, T.M.2    Konst, E.M.3
  • 19
    • 0030836029 scopus 로고    scopus 로고
    • Confidence intervals for cost-effectiveness ratios: a comparison of four methods
    • Polsky D, Glick HA, Willke R et al. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ 1997;6:243-52.
    • (1997) Health Econ , vol.6 , pp. 243-252
    • Polsky, D.1    Glick, H.A.2    Willke, R.3
  • 20
    • 0035869680 scopus 로고    scopus 로고
    • Bayesian costeffectiveness analysis from clinical trial data
    • O'Hagan A, Stevens JW, Montmartin J. Bayesian costeffectiveness analysis from clinical trial data. Stat Med 2001;20:733-53.
    • (2001) Stat Med , vol.20 , pp. 733-753
    • O'Hagan, A.1    Stevens, J.W.2    Montmartin, J.3
  • 21
    • 0034010546 scopus 로고    scopus 로고
    • Inference for the costeffectiveness acceptability curve and cost-effectiveness ratio
    • O'Hagan A, Stevens JW, Montmartin J. Inference for the costeffectiveness acceptability curve and cost-effectiveness ratio. Pharmacoeconomics 2000;17:339-49.
    • (2000) Pharmacoeconomics , vol.17 , pp. 339-349
    • O'Hagan, A.1    Stevens, J.W.2    Montmartin, J.3
  • 22
    • 0037207519 scopus 로고    scopus 로고
    • Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
    • O'Hagan A, Stevens JW. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Econ 2003;12:33-49.
    • (2003) Health Econ , vol.12 , pp. 33-49
    • O'Hagan, A.1    Stevens, J.W.2
  • 24
    • 0036946477 scopus 로고    scopus 로고
    • Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies
    • O'Hagan A, Stevens JW. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat Methods Med Res 2002;11:469-90.
    • (2002) Stat Methods Med Res , vol.11 , pp. 469-490
    • O'Hagan, A.1    Stevens, J.W.2
  • 25
    • 0034950339 scopus 로고    scopus 로고
    • A framework for cost-effectiveness analysis from clinical trial data
    • O'Hagan A, Stevens JW. A framework for cost-effectiveness analysis from clinical trial data. Health Econ 2001;10:303-15.
    • (2001) Health Econ , vol.10 , pp. 303-315
    • O'Hagan, A.1    Stevens, J.W.2
  • 26
    • 0036946469 scopus 로고    scopus 로고
    • Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods
    • O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002;11:455-68.
    • (2002) Stat Methods Med Res , vol.11 , pp. 455-468
    • O'Brien, B.J.1    Briggs, A.H.2
  • 27
    • 0033761319 scopus 로고    scopus 로고
    • Definition, interpretation and calculation of cost-effectiveness acceptability curves
    • Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ 2000;9:623-30.
    • (2000) Health Econ , vol.9 , pp. 623-630
    • Lothgren, M.1    Zethraeus, N.2
  • 28
    • 0036203753 scopus 로고    scopus 로고
    • Statistical determination of cost-effectiveness frontier based on net health benefits
    • Laska EM, Meisner M, Siegel C et al. Statistical determination of cost-effectiveness frontier based on net health benefits. Health Econ 2002;11:249-64.
    • (2002) Health Econ , vol.11 , pp. 249-264
    • Laska, E.M.1    Meisner, M.2    Siegel, C.3
  • 29
    • 0030666453 scopus 로고    scopus 로고
    • The usefulness of average cost-effective ratios
    • Laska EM, Meisner M, Siegel C. The usefulness of average cost-effective ratios. Health Econ 1997;6:497-504.
    • (1997) Health Econ , vol.6 , pp. 497-504
    • Laska, E.M.1    Meisner, M.2    Siegel, C.3
  • 30
    • 0030849288 scopus 로고    scopus 로고
    • Statistical inference for costeffectiveness ratios
    • Laska EM, Meisner M, Siegel C. Statistical inference for costeffectiveness ratios. Health Econ 1997;6:229-42.
    • (1997) Health Econ , vol.6 , pp. 229-242
    • Laska, E.M.1    Meisner, M.2    Siegel, C.3
  • 31
    • 0034088238 scopus 로고    scopus 로고
    • Fieller's method and net health benefits
    • Heitjan DF. Fieller's method and net health benefits. Health Econ 2000;9:327-35.
    • (2000) Health Econ , vol.9 , pp. 327-335
    • Heitjan, D.F.1
  • 32
    • 0032943122 scopus 로고    scopus 로고
    • Bayesian estimation of cost-effectiveness ratios from clinical trials
    • Heitjan DF, Moskowitz AJ, Whang W. Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Econ 1999;8:191-201.
    • (1999) Health Econ , vol.8 , pp. 191-201
    • Heitjan, D.F.1    Moskowitz, A.J.2    Whang, W.3
  • 33
    • 0032894376 scopus 로고    scopus 로고
    • Problems with interval estimates of the incremental cost-effectiveness ratio
    • Heitjan DF, Moskowitz AJ, Whang W. Problems with interval estimates of the incremental cost-effectiveness ratio. Med Decis Making 1999;19:9-15.
    • (1999) Med Decis Making , vol.19 , pp. 9-15
    • Heitjan, D.F.1    Moskowitz, A.J.2    Whang, W.3
  • 34
    • 0035669803 scopus 로고    scopus 로고
    • Representing uncertainty: the role of cost-effectiveness acceptability curves
    • Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87.
    • (2001) Health Econ , vol.10 , pp. 779-787
    • Fenwick, E.1    Claxton, K.2    Sculpher, M.3
  • 35
    • 0032925086 scopus 로고    scopus 로고
    • A Bayesian approach to stochastic cost-effectiveness analysis
    • Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ 1999;8:257-61.
    • (1999) Health Econ , vol.8 , pp. 257-261
    • Briggs, A.H.1
  • 36
    • 0034086702 scopus 로고    scopus 로고
    • Handling uncertainty in cost-effectiveness models
    • Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000;17:479-500.
    • (2000) Pharmacoeconomics , vol.17 , pp. 479-500
    • Briggs, A.H.1
  • 37
    • 0033573275 scopus 로고    scopus 로고
    • Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation
    • Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med 1999;18:3245-62.
    • (1999) Stat Med , vol.18 , pp. 3245-3262
    • Briggs, A.H.1    Mooney, C.Z.2    Wonderling, D.E.3
  • 38
    • 0036246479 scopus 로고    scopus 로고
    • Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies
    • Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002;23:377-401.
    • (2002) Annu Rev Public Health , vol.23 , pp. 377-401
    • Briggs, A.H.1    O'Brien, B.J.2    Blackhouse, G.3
  • 39
    • 0030853766 scopus 로고    scopus 로고
    • Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation
    • Briggs AH, Wonderling DE, Mooney CZ. Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
    • (1997) Health Econ , vol.6 , pp. 327-340
    • Briggs, A.H.1    Wonderling, D.E.2    Mooney, C.Z.3
  • 40
    • 0030666452 scopus 로고    scopus 로고
    • Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'
    • Briggs A, Fenn P. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'. Health Econ 1997;6:491-5.
    • (1997) Health Econ , vol.6 , pp. 491-495
    • Briggs, A.1    Fenn, P.2
  • 41
    • 0029366453 scopus 로고
    • Confidence intervals for cost/effectiveness ratios
    • Wakker P, Klaassen MP. Confidence intervals for cost/effectiveness ratios. Health Econ 1995;4:373-81.
    • (1995) Health Econ , vol.4 , pp. 373-381
    • Wakker, P.1    Klaassen, M.P.2
  • 42
    • 0031989253 scopus 로고    scopus 로고
    • Some reflections on costeffectiveness analysis
    • Johannesson M, Meltzer D. Some reflections on costeffectiveness analysis. Health Econ 1998;7:1-7.
    • (1998) Health Econ , vol.7 , pp. 1-7
    • Johannesson, M.1    Meltzer, D.2
  • 43
    • 0032408402 scopus 로고    scopus 로고
    • Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane
    • Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998;7:723-40.
    • (1998) Health Econ , vol.7 , pp. 723-740
    • Briggs, A.1    Fenn, P.2
  • 44
    • 33745248689 scopus 로고    scopus 로고
    • Nonparametric statistical methods for costeffectiveness analyses
    • Dinh P, Zhou XH. Nonparametric statistical methods for costeffectiveness analyses. Biometrics 2006;62:576-88.
    • (2006) Biometrics , vol.62 , pp. 576-588
    • Dinh, P.1    Zhou, X.H.2
  • 45
    • 17844409064 scopus 로고    scopus 로고
    • Conducting economic evaluations alongside multinational clinical trials: toward a research consensus
    • Reed SD, Anstrom KJ, Bakhai A et al. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 2005;149:434-43.
    • (2005) Am Heart J , vol.149 , pp. 434-443
    • Reed, S.D.1    Anstrom, K.J.2    Bakhai, A.3
  • 46
    • 27744468588 scopus 로고    scopus 로고
    • Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
    • Ramsey S, Willke R, Briggs A et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521-33.
    • (2005) Value Health , vol.8 , pp. 521-533
    • Ramsey, S.1    Willke, R.2    Briggs, A.3
  • 47
    • 58349110979 scopus 로고    scopus 로고
    • Assessing the impact of drug use on hospital costs
    • Stuart BC, Doshi JA, Terza JV. Assessing the impact of drug use on hospital costs. Health Serv Res 2009;44:128-44.
    • (2009) Health Serv Res , vol.44 , pp. 128-144
    • Stuart, B.C.1    Doshi, J.A.2    Terza, J.V.3
  • 48
    • 60349109642 scopus 로고    scopus 로고
    • Extreme regression models for characterizing high-cost patients
    • Gregori D, Petrinco M, Barbati G et al. Extreme regression models for characterizing high-cost patients. J Eval Clin Pract 2009;15:164-71.
    • (2009) J Eval Clin Pract , vol.15 , pp. 164-171
    • Gregori, D.1    Petrinco, M.2    Barbati, G.3
  • 49
    • 41149096954 scopus 로고    scopus 로고
    • Regression tree boosting to adjust health care cost predictions for diagnostic mix
    • Robinson JW. Regression tree boosting to adjust health care cost predictions for diagnostic mix. Health Serv Res 2008;43:755-72.
    • (2008) Health Serv Res , vol.43 , pp. 755-772
    • Robinson, J.W.1
  • 50
    • 58849165404 scopus 로고    scopus 로고
    • Hospital costs estimation and prediction as a function of patient and admission characteristics
    • Ramiarina R, Almeida RM, Pereira WC. Hospital costs estimation and prediction as a function of patient and admission characteristics. Int J Health Plann Manage 2008;23:345-55.
    • (2008) Int J Health Plann Manage , vol.23 , pp. 345-355
    • Ramiarina, R.1    Almeida, R.M.2    Pereira, W.C.3
  • 51
    • 9644302446 scopus 로고    scopus 로고
    • Patients with type 2 diabetes had higher rates of hospitalization than the general population
    • Bo S, Ciccone G, Grassi G et al. Patients with type 2 diabetes had higher rates of hospitalization than the general population. J Clin Epidemiol 2004;57:1196-201.
    • (2004) J Clin Epidemiol , vol.57 , pp. 1196-1201
    • Bo, S.1    Ciccone, G.2    Grassi, G.3
  • 52
    • 56449122776 scopus 로고    scopus 로고
    • Factors affecting hospitalization costs in Type 2 diabetic patients
    • Pagano E, Bo S, Petrinco M et al. Factors affecting hospitalization costs in Type 2 diabetic patients. J Diabetes Complications 2009;23:1-6.
    • (2009) J Diabetes Complications , vol.23 , pp. 1-6
    • Pagano, E.1    Bo, S.2    Petrinco, M.3
  • 53
    • 0141510068 scopus 로고    scopus 로고
    • Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction
    • Desideri A, Fioretti PM, Cortigiani L et al. Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction. Eur Heart J 2003;24:1630-9.
    • (2003) Eur Heart J , vol.24 , pp. 1630-1639
    • Desideri, A.1    Fioretti, P.M.2    Cortigiani, L.3
  • 54
    • 19944433181 scopus 로고    scopus 로고
    • Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial
    • Desideri A, Fioretti PM, Cortigiani L et al. Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial. Heart 2005;91:146-51.
    • (2005) Heart , vol.91 , pp. 146-151
    • Desideri, A.1    Fioretti, P.M.2    Cortigiani, L.3
  • 55
    • 0027461730 scopus 로고
    • Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery
    • Dudley RA, Harrell FE, Jr., Smith LR et al. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. J Clin Epidemiol 1993;46:261-71.
    • (1993) J Clin Epidemiol , vol.46 , pp. 261-271
    • Dudley, R.A.1    Harrell Jr., F.E.2    Smith, L.R.3
  • 56
    • 0033050856 scopus 로고    scopus 로고
    • On the use of survival analysis techniques to estimate medical care costs
    • Etzioni RD, Feuer EJ, Sullivan SD et al. On the use of survival analysis techniques to estimate medical care costs. J Health Econ 1999;18:365-80.
    • (1999) J Health Econ , vol.18 , pp. 365-380
    • Etzioni, R.D.1    Feuer, E.J.2    Sullivan, S.D.3
  • 57
    • 0031897990 scopus 로고    scopus 로고
    • Predicting the cost of illness: a comparison of alternative models applied to stroke
    • Lipscomb J, Ancukiewicz M, Parmigiani G et al. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998;18(2 Suppl):S39-56.
    • (1998) Med Decis Making , vol.18 , Issue.2 SUPPL.
    • Lipscomb, J.1    Ancukiewicz, M.2    Parmigiani, G.3
  • 58
    • 0034993174 scopus 로고    scopus 로고
    • Estimating log models: to transform or not to transform?
    • Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461-94.
    • (2001) J Health Econ , vol.20 , pp. 461-494
    • Manning, W.G.1    Mullahy, J.2
  • 59
    • 0028510646 scopus 로고
    • Statistical analysis of cost outcomes in a randomized controlled clinical trial
    • Rutten-van Molken MP, van Doorslaer EK, van Vliet RC. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Econ 1994;3:333-45.
    • (1994) Health Econ , vol.3 , pp. 333-345
    • Rutten-van Molken, M.P.1    van Doorslaer, E.K.2    van Vliet, R.C.3
  • 60
    • 26044462174 scopus 로고    scopus 로고
    • Assessing household health expenditure with Box-Cox censoring models
    • Chaze JP. Assessing household health expenditure with Box-Cox censoring models. Health Econ 2005;14:893-907.
    • (2005) Health Econ , vol.14 , pp. 893-907
    • Chaze, J.P.1
  • 61
    • 4344617705 scopus 로고    scopus 로고
    • Comparing alternative models: log vs Cox proportional hazard?
    • Basu A, Manning WG, Mullahy J. Comparing alternative models: log vs Cox proportional hazard? Health Econ 2004;13:749-65.
    • (2004) Health Econ , vol.13 , pp. 749-765
    • Basu, A.1    Manning, W.G.2    Mullahy, J.3
  • 62
    • 7044221846 scopus 로고    scopus 로고
    • Multiple regression of cost data: use of generalised linear models
    • Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004;9:197-204.
    • (2004) J Health Serv Res Policy , vol.9 , pp. 197-204
    • Barber, J.1    Thompson, S.2
  • 63
    • 16244380534 scopus 로고    scopus 로고
    • Generalized modeling approaches to risk adjustment of skewed outcomes data
    • Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-88.
    • (2005) J Health Econ , vol.24 , pp. 465-488
    • Manning, W.G.1    Basu, A.2    Mullahy, J.3
  • 64
    • 0036523763 scopus 로고    scopus 로고
    • A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment
    • Kilian R, Matschinger H, Loeffler W et al. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. J Ment Health Policy Econ 2002;5:21-31.
    • (2002) J Ment Health Policy Econ , vol.5 , pp. 21-31
    • Kilian, R.1    Matschinger, H.2    Loeffler, W.3
  • 65
    • 68349116023 scopus 로고    scopus 로고
    • Some notes on parametric link functions in clinical research
    • Baldi I, Maule M, Bigi R et al. Some notes on parametric link functions in clinical research. Stat Methods Med Res 2009;18:131-44.
    • (2009) Stat Methods Med Res , vol.18 , pp. 131-144
    • Baldi, I.1    Maule, M.2    Bigi, R.3
  • 66
    • 51949111620 scopus 로고
    • Smearing estimate: a non parametric retransformation method
    • Duan N. Smearing estimate: a non parametric retransformation method. J Am Stat Assoc 1983;78:605-10.
    • (1983) J Am Stat Assoc , vol.78 , pp. 605-610
    • Duan, N.1
  • 67
    • 3142702323 scopus 로고
    • Tobit models: a survey
    • Amemiya T. Tobit models: a survey. J Econ 1981;24:3-61.
    • (1981) J Econ , vol.24 , pp. 3-61
    • Amemiya, T.1
  • 68
    • 0001565817 scopus 로고
    • On the asymptotic bias of the ordinary least squares estimator of the Tobit model
    • Greene WH. On the asymptotic bias of the ordinary least squares estimator of the Tobit model. Econometrica 1981;49:505-13.
    • (1981) Econometrica , vol.49 , pp. 505-513
    • Greene, W.H.1
  • 69
    • 34548741391 scopus 로고    scopus 로고
    • A two-part model for censored medical cost data
    • Tian L, Huang J. A two-part model for censored medical cost data. Stat Med 2007;26:4273-92.
    • (2007) Stat Med , vol.26 , pp. 4273-4292
    • Tian, L.1    Huang, J.2
  • 70
    • 42249092645 scopus 로고    scopus 로고
    • A computer program for estimating the re-transformed mean in heteroscedastic two-part models
    • Zhou XH, Cheng H. A computer program for estimating the re-transformed mean in heteroscedastic two-part models. Comput Methods Programs Biomed 2008;90:210-6.
    • (2008) Comput Methods Programs Biomed , vol.90 , pp. 210-216
    • Zhou, X.H.1    Cheng, H.2
  • 71
    • 56449122776 scopus 로고    scopus 로고
    • Factors affecting hospitalization costs in Type 2 diabetic patients
    • Pagano E, Bo S, Petrinco M et al. Factors affecting hospitalization costs in Type 2 diabetic patients. J Diabetes Complications 2009;23:1-6.
    • (2009) J Diabetes Complications , vol.23 , pp. 1-6
    • Pagano, E.1    Bo, S.2    Petrinco, M.3
  • 72
    • 84947396376 scopus 로고
    • A generalization of sampling without replacement from a finite universe
    • Horvitz DG, Thompson DJ. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 1952;47:663-85.
    • (1952) J Am Stat Assoc , vol.47 , pp. 663-685
    • Horvitz, D.G.1    Thompson, D.J.2
  • 73
    • 0001149964 scopus 로고    scopus 로고
    • Estimating medical cost with censored data
    • Bang H, Tsiatis A. Estimating medical cost with censored data. Biometirka 2000;87:329-43.
    • (2000) Biometirka , vol.87 , pp. 329-343
    • Bang, H.1    Tsiatis, A.2
  • 74
    • 0030910046 scopus 로고    scopus 로고
    • Estimating medical costs from incomplete follow-up data
    • Lin DY, Feuer EJ, Etzioni R et al. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53: 419-34.
    • (1997) Biometrics , vol.53 , pp. 419-434
    • Lin, D.Y.1    Feuer, E.J.2    Etzioni, R.3
  • 75
    • 35148881504 scopus 로고    scopus 로고
    • On the equivalence of some medical cost estimators with censored data
    • Zhao H, Bang H, Wang H et al. On the equivalence of some medical cost estimators with censored data. Stat Med 2007;26:4520-30.
    • (2007) Stat Med , vol.26 , pp. 4520-4530
    • Zhao, H.1    Bang, H.2    Wang, H.3
  • 76
    • 2342567056 scopus 로고    scopus 로고
    • On estimators of medical costs with censored data
    • O'Hagan A, Stevens JW. On estimators of medical costs with censored data. J Health Econ 2004;23:615-25.
    • (2004) J Health Econ , vol.23 , pp. 615-625
    • O'Hagan, A.1    Stevens, J.W.2
  • 77
    • 7744238303 scopus 로고    scopus 로고
    • Bootstrap confidence intervals for medical costs with censored observations
    • Jiang H, Zhou XH. Bootstrap confidence intervals for medical costs with censored observations. Stat Med 2004;23:3365-76.
    • (2004) Stat Med , vol.23 , pp. 3365-3376
    • Jiang, H.1    Zhou, X.H.2
  • 78
    • 0024401372 scopus 로고
    • A linear regression model for the analysis of life times
    • Aalen OO. A linear regression model for the analysis of life times. Stat Med 1989;8:907-25.
    • (1989) Stat Med , vol.8 , pp. 907-925
    • Aalen, O.O.1
  • 79
    • 0027185065 scopus 로고
    • Further results on the non-parametric linear regression model in survival analysis
    • Aalen OO. Further results on the non-parametric linear regression model in survival analysis. Stat Med 1993;12: 1569-88.
    • (1993) Stat Med , vol.12 , pp. 1569-1588
    • Aalen, O.O.1
  • 80
    • 48249139863 scopus 로고    scopus 로고
    • Survival models for cost data: the forgotten additive approach
    • Pagano E, Petrinco M, Desideri A et al. Survival models for cost data: the forgotten additive approach. Stat Med 2008;27:3585-97.
    • (2008) Stat Med , vol.27 , pp. 3585-3597
    • Pagano, E.1    Petrinco, M.2    Desideri, A.3
  • 81
    • 49349099514 scopus 로고    scopus 로고
    • Proper modeling strategies selection for the assessment of post-infarction costs
    • Gregori D, Desideri A, Bigi R et al. Proper modeling strategies selection for the assessment of post-infarction costs. Int J Cardiol 2008;129:53-8.
    • (2008) Int J Cardiol , vol.129 , pp. 53-58
    • Gregori, D.1    Desideri, A.2    Bigi, R.3
  • 82
    • 0036561353 scopus 로고    scopus 로고
    • The medical expenditure panel survey: an overview
    • Cohen SB. The medical expenditure panel survey: an overview. Eff Clin Pract 2002;5(3 Suppl):E1.
    • (2002) Eff Clin Pract , vol.5 , Issue.3 SUPPL.
    • Cohen, S.B.1
  • 83
    • 0041305855 scopus 로고    scopus 로고
    • Regression-based sampling for persons with high health expenditures: evaluating accuracy and yield with the 1997 MEPS
    • Moeller JF, Cohen SB, Mathiowetz NA et al. Regression-based sampling for persons with high health expenditures: evaluating accuracy and yield with the 1997 MEPS. Med Care 2003; 41(7 Suppl):III44-52.
    • (2003) Med Care , vol.41 , Issue.7 SUPPL.
    • Moeller, J.F.1    Cohen, S.B.2    Mathiowetz, N.A.3
  • 84
    • 33750532528 scopus 로고    scopus 로고
    • Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter?
    • Gregori D, Pagano E, Rosato R et al. Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter? Curr Med Res Opin 2006;22:1965-71.
    • (2006) Curr Med Res Opin , vol.22 , pp. 1965-1971
    • Gregori, D.1    Pagano, E.2    Rosato, R.3
  • 85
    • 67651155895 scopus 로고    scopus 로고
    • Issues for the next generation of health care cost analyses
    • Basu A, Manning WG. Issues for the next generation of health care cost analyses. Med Care 2009;47(7 Suppl 1): S109-14.
    • (2009) Med Care , vol.47 , Issue.7 SUPPL. 1
    • Basu, A.1    Manning, W.G.2
  • 86
    • 0030910046 scopus 로고    scopus 로고
    • Estimating medical costs from incomplete follow up data
    • Lin D, Feuer E, Etzioni R et al. Estimating medical costs from incomplete follow up data. Biometrics 1997;53:419-34.
    • (1997) Biometrics , vol.53 , pp. 419-434
    • Lin, D.1    Feuer, E.2    Etzioni, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.